Transit Time Flow Measurement in Coronary Surgery
COLLATERAL
1 other identifier
observational
135
1 country
1
Brief Summary
Transit-time flowmetry (TTFM) allows grafts quality control during coronary artery bypass surgery by measuring the flow volume through them. To date, many studies have deeply studied the predictive role on the graft outcomes of the various flowmetry-derived parameters. One of the least investigated aspects, however, is the mutual influence that two newly realized grafts can have. This possibility would be related to the presence of a more or less developed collateral circulation between the bypassed territories. The purpose of this study is to assess whether a graft for a territory different than that provided by the left anterior descending artery (LAD) may affect the functionality (measured through flowmetry) of the left internal mammary artery - LAD graft.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2024
CompletedFirst Posted
Study publicly available on registry
June 24, 2024
CompletedStudy Start
First participant enrolled
November 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 20, 2025
CompletedNovember 27, 2024
November 1, 2024
6 months
May 28, 2024
November 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
LIMA>LAD Pulsatility index (PI) modification
The primary aim of this study is to assess whether a graft for a non-LAD coronary target modifies the performance (measured by flowmetry) of the flow in the LIMA\>LAD graft. PI is expressed by the ratio of the flow volume amplitude and mean flow volume, both quantified by a flowmeter (ml/min / ml/min). An ideal value would be \< 3
During the surgery, out of cardiopulmonary bypass
Secondary Outcomes (5)
LIMA>LAD mean flow change
During surgery, before and after transient occlusion of the other grafts for non-LAD coronary targets
LIMA>LAD Diastolic filling (%DF) change
During surgery,before and after transient occlusion of the other grafts for non-LAD coronary targets.
variation of Diastolic filling (%DF) on the right coronary
During surgery,before and after transient occlusion of the other grafts for non-LAD coronary targets.
LIMA>LAD % Backward flow (BF) change
During surgery, before and after transient occlusion of the other grafts for non-LAD coronary targets.
mean flow, Pulsatility Index, Diastolic filling (%DF) and Diastolic filling (%DF) in the non-LAD grafts
During surgery, before and after transient occlusion of the LIMA>LAD graft
Eligibility Criteria
All patients with coronary artery disease and an indication for surgical revascularization (coronary artery bypass grafting) who meet the above-described inclusion and exclusion criteria will be enrolled by signing the informed consent the day before surgery.
You may qualify if:
- age \> 18 years;
- informed consent acquired and registered;
- patients who undergo coronary artery bypass grafting (with or without cardiopulmonary bypass);
- patients with stable angina, unstable angina or acute coronary syndrome without elevation of the ST tract (NSTEMI)
You may not qualify if:
- patients unable to give informed consent;
- patients undergoing emergency surgery;
- patients in unstable haemodynamic conditions or in need of pharmacological or mechanical support;
- patients undergoing combined surgery;
- patients undergoing single aortocoronary bypass surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione Policlinico Gemelli IRCCS
Roma, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
federico cammertoni
Fondazione Policlinico Gemelli IRCCS
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
May 28, 2024
First Posted
June 24, 2024
Study Start
November 20, 2024
Primary Completion
May 20, 2025
Study Completion
October 20, 2025
Last Updated
November 27, 2024
Record last verified: 2024-11